Tag: cancer

DC joins 37 states in passing Breast Density Screening and Notification Act to address little known risk factor for breast ...

ATLANTA -- Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory acute myeloid leukemia ...

ATLANTA -- Vaccination with as few as four tumor antigens generated antigen-specific responses, reduced intestinal tumors, and improved survival in ...

ATLANTA -- The investigational therapeutic umbralisib, which targets the molecule PI3K-delta, was well tolerated and highly active in patients with ...

ATLANTA -- The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumor activity with durable responses in patients with pretreated, advanced ...

Data presented at AACR Annual Meeting on recently approved drug that targets common mutation in AML ATLANTA - An inhibitor ...

MD Anderson Phase II trial shows drug well tolerated with high response rates for marginal zone lymphomaCredit: MD Anderson Cancer ...

Credit: Tae Hyun Kim ANN ARBOR, Michigan -- A prototype wearable device, tested in animal models, can continuously collect live ...

Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (April 1, 2019) - When a breast cancer tumor is removed ...

A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial. (PHILADELPHIA) ...

Study results to be presented during a plenary session at AACR Annual Meeting ATLANTA - A new combination of immunotherapy ...

ATLANTA --Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk than excess weight at ...

Computational tools seek to identify pancreatic cancer earlier, provide more opportunities for timely, effective treatmentsCredit: Pancreatic Cancer Collective (ATLANTA - ...

Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to ...

ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who ...

ATLANTA -- A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among ...

ATLANTA -- A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was ...

ATLANTA -- A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity ...

An essential part of breast intervention is the process of assessing concordance between imaging findings and core biopsy results. When ...

A new study published in the April 2019 issue of the American Journal of Roentgenology (AJR) considers several potential factors ...